世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ウンデシル酸テストステロン（TU）の世界および日本の市場規模、現状、予測 2021-2027年

Global and Japan Testosterone Undecylate (TU) Market Size, Status and Forecast 2021-2027

ウンデカン酸テストステロンは、テストステロンのエステル型プロドラッグで、17β位に中鎖脂肪酸を有している。市場分析と洞察。ウンデシル酸テストステロン（TU）の世界市場ウンデシル酸テストステロン（TU... もっと見る

出版社	出版年月	電子版価格	納期	言語
QYResearch QYリサーチ	2021年11月26日	US$3,900 シングルユーザライセンスライセンス・価格情報注文方法はこちら	5-7営業日	英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

ウンデカン酸テストステロンは、テストステロンのエステル型プロドラッグで、17β位に中鎖脂肪酸を有している。

市場分析と洞察。ウンデシル酸テストステロン（TU）の世界市場
ウンデシル酸テストステロン（TU）の世界市場規模は、2020年のXX百万米ドルから2021-2027年の間にXX％のCAGRで推移し、2027年にはXX百万米ドルに達すると予測されています。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界のTestosterone Undecylate (TU)市場で得られる主要な機会を明らかにし、プレイヤーが市場での強力なポジションを獲得するのに役立つよう、見事な試みを行っています。本レポートの購入者は、世界のTestosterone Undecylate (TU)市場の全体的なサイズ（収益）など、検証済みの信頼できる市場予測にアクセスすることができます。
本レポートは、世界のTestosterone Undecylate (TU)市場において、競合他社よりも優位に立ち、永続的な成功を収めるための有効なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界のTestosterone Undecylate (TU)市場を詳細に調査するために、ユニークで業界最高の調査・分析アプローチを採用しました。

世界のウンデシル酸テストステロン（TU）のスコープと市場規模
ウンデシル酸テストステロン（TU）市場は、企業別、地域（国）別、タイプ別、用途別に分類されています。ウンデシル酸テストステロン（TU）の世界市場に参加しているプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間におけるタイプ別、アプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
注射
口腔用

アプリケーション別
原発性性腺機能低下症
低ゴナドトロピック性性腺機能低下症
晩発性性腺機能低下症

地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
オルガノン
バイエルAG
エンド・ファーマシューティカルズ
メルク・シャープ＆ドーム社
太郎薬品
シプラ社
クララス・セラピューティクス
浙江省仙寿製薬
浙江省医学

ページTOPに戻る

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Testosterone Undecylate (TU) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Injection
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Testosterone Undecylate (TU) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Primary Hypogonadism
1.3.3 Hypogonadotropic Hypogonadism
1.3.4 Late-Onset Hypogonadism
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Testosterone Undecylate (TU) Market Perspective (2016-2027)
2.2 Testosterone Undecylate (TU) Growth Trends by Regions
2.2.1 Testosterone Undecylate (TU) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Testosterone Undecylate (TU) Historic Market Share by Regions (2016-2021)
2.2.3 Testosterone Undecylate (TU) Forecasted Market Size by Regions (2022-2027)
2.3 Testosterone Undecylate (TU) Industry Dynamic
2.3.1 Testosterone Undecylate (TU) Market Trends
2.3.2 Testosterone Undecylate (TU) Market Drivers
2.3.3 Testosterone Undecylate (TU) Market Challenges
2.3.4 Testosterone Undecylate (TU) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Testosterone Undecylate (TU) Players by Revenue
3.1.1 Global Top Testosterone Undecylate (TU) Players by Revenue (2016-2021)
3.1.2 Global Testosterone Undecylate (TU) Revenue Market Share by Players (2016-2021)
3.2 Global Testosterone Undecylate (TU) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Testosterone Undecylate (TU) Revenue
3.4 Global Testosterone Undecylate (TU) Market Concentration Ratio
3.4.1 Global Testosterone Undecylate (TU) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Testosterone Undecylate (TU) Revenue in 2020
3.5 Testosterone Undecylate (TU) Key Players Head office and Area Served
3.6 Key Players Testosterone Undecylate (TU) Product Solution and Service
3.7 Date of Enter into Testosterone Undecylate (TU) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Testosterone Undecylate (TU) Breakdown Data by Type
4.1 Global Testosterone Undecylate (TU) Historic Market Size by Type (2016-2021)
4.2 Global Testosterone Undecylate (TU) Forecasted Market Size by Type (2022-2027)

5 Testosterone Undecylate (TU) Breakdown Data by Application
5.1 Global Testosterone Undecylate (TU) Historic Market Size by Application (2016-2021)
5.2 Global Testosterone Undecylate (TU) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Testosterone Undecylate (TU) Market Size (2016-2027)
6.2 North America Testosterone Undecylate (TU) Market Size by Type
6.2.1 North America Testosterone Undecylate (TU) Market Size by Type (2016-2021)
6.2.2 North America Testosterone Undecylate (TU) Market Size by Type (2022-2027)
6.2.3 North America Testosterone Undecylate (TU) Market Size by Type (2016-2027)
6.3 North America Testosterone Undecylate (TU) Market Size by Application
6.3.1 North America Testosterone Undecylate (TU) Market Size by Application (2016-2021)
6.3.2 North America Testosterone Undecylate (TU) Market Size by Application (2022-2027)
6.3.3 North America Testosterone Undecylate (TU) Market Size by Application (2016-2027)
6.4 North America Testosterone Undecylate (TU) Market Size by Country
6.4.1 North America Testosterone Undecylate (TU) Market Size by Country (2016-2021)
6.4.2 North America Testosterone Undecylate (TU) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Testosterone Undecylate (TU) Market Size (2016-2027)
7.2 Europe Testosterone Undecylate (TU) Market Size by Type
7.2.1 Europe Testosterone Undecylate (TU) Market Size by Type (2016-2021)
7.2.2 Europe Testosterone Undecylate (TU) Market Size by Type (2022-2027)
7.2.3 Europe Testosterone Undecylate (TU) Market Size by Type (2016-2027)
7.3 Europe Testosterone Undecylate (TU) Market Size by Application
7.3.1 Europe Testosterone Undecylate (TU) Market Size by Application (2016-2021)
7.3.2 Europe Testosterone Undecylate (TU) Market Size by Application (2022-2027)
7.3.3 Europe Testosterone Undecylate (TU) Market Size by Application (2016-2027)
7.4 Europe Testosterone Undecylate (TU) Market Size by Country
7.4.1 Europe Testosterone Undecylate (TU) Market Size by Country (2016-2021)
7.4.2 Europe Testosterone Undecylate (TU) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Testosterone Undecylate (TU) Market Size (2016-2027)
8.2 Asia-Pacific Testosterone Undecylate (TU) Market Size by Type
8.2.1 Asia-Pacific Testosterone Undecylate (TU) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Testosterone Undecylate (TU) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Testosterone Undecylate (TU) Market Size by Type (2016-2027)
8.3 Asia-Pacific Testosterone Undecylate (TU) Market Size by Application
8.3.1 Asia-Pacific Testosterone Undecylate (TU) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Testosterone Undecylate (TU) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Testosterone Undecylate (TU) Market Size by Application (2016-2027)
8.4 Asia-Pacific Testosterone Undecylate (TU) Market Size by Region
8.4.1 Asia-Pacific Testosterone Undecylate (TU) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Testosterone Undecylate (TU) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Testosterone Undecylate (TU) Market Size (2016-2027)
9.2 Latin America Testosterone Undecylate (TU) Market Size by Type
9.2.1 Latin America Testosterone Undecylate (TU) Market Size by Type (2016-2021)
9.2.2 Latin America Testosterone Undecylate (TU) Market Size by Type (2022-2027)
9.2.3 Latin America Testosterone Undecylate (TU) Market Size by Type (2016-2027)
9.3 Latin America Testosterone Undecylate (TU) Market Size by Application
9.3.1 Latin America Testosterone Undecylate (TU) Market Size by Application (2016-2021)
9.3.2 Latin America Testosterone Undecylate (TU) Market Size by Application (2022-2027)
9.3.3 Latin America Testosterone Undecylate (TU) Market Size by Application (2016-2027)
9.4 Latin America Testosterone Undecylate (TU) Market Size by Country
9.4.1 Latin America Testosterone Undecylate (TU) Market Size by Country (2016-2021)
9.4.2 Latin America Testosterone Undecylate (TU) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Testosterone Undecylate (TU) Market Size (2016-2027)
10.2 Middle East & Africa Testosterone Undecylate (TU) Market Size by Type
10.2.1 Middle East & Africa Testosterone Undecylate (TU) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Testosterone Undecylate (TU) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Testosterone Undecylate (TU) Market Size by Type (2016-2027)
10.3 Middle East & Africa Testosterone Undecylate (TU) Market Size by Application
10.3.1 Middle East & Africa Testosterone Undecylate (TU) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Testosterone Undecylate (TU) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Testosterone Undecylate (TU) Market Size by Application (2016-2027)
10.4 Middle East & Africa Testosterone Undecylate (TU) Market Size by Country
10.4.1 Middle East & Africa Testosterone Undecylate (TU) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Testosterone Undecylate (TU) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Organon
11.1.1 Organon Company Details
11.1.2 Organon Business Overview
11.1.3 Organon Testosterone Undecylate (TU) Introduction
11.1.4 Organon Revenue in Testosterone Undecylate (TU) Business (2016-2021)
11.1.5 Organon Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Details
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG Testosterone Undecylate (TU) Introduction
11.2.4 Bayer AG Revenue in Testosterone Undecylate (TU) Business (2016-2021)
11.2.5 Bayer AG Recent Development
11.3 Endo Pharmaceuticals
11.3.1 Endo Pharmaceuticals Company Details
11.3.2 Endo Pharmaceuticals Business Overview
11.3.3 Endo Pharmaceuticals Testosterone Undecylate (TU) Introduction
11.3.4 Endo Pharmaceuticals Revenue in Testosterone Undecylate (TU) Business (2016-2021)
11.3.5 Endo Pharmaceuticals Recent Development
11.4 Merck Sharp & Dohme
11.4.1 Merck Sharp & Dohme Company Details
11.4.2 Merck Sharp & Dohme Business Overview
11.4.3 Merck Sharp & Dohme Testosterone Undecylate (TU) Introduction
11.4.4 Merck Sharp & Dohme Revenue in Testosterone Undecylate (TU) Business (2016-2021)
11.4.5 Merck Sharp & Dohme Recent Development
11.5 Taro Pharmaceutical
11.5.1 Taro Pharmaceutical Company Details
11.5.2 Taro Pharmaceutical Business Overview
11.5.3 Taro Pharmaceutical Testosterone Undecylate (TU) Introduction
11.5.4 Taro Pharmaceutical Revenue in Testosterone Undecylate (TU) Business (2016-2021)
11.5.5 Taro Pharmaceutical Recent Development
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla Testosterone Undecylate (TU) Introduction
11.6.4 Cipla Revenue in Testosterone Undecylate (TU) Business (2016-2021)
11.6.5 Cipla Recent Development
11.7 Clarus Therapeutics
11.7.1 Clarus Therapeutics Company Details
11.7.2 Clarus Therapeutics Business Overview
11.7.3 Clarus Therapeutics Testosterone Undecylate (TU) Introduction
11.7.4 Clarus Therapeutics Revenue in Testosterone Undecylate (TU) Business (2016-2021)
11.7.5 Clarus Therapeutics Recent Development
11.8 Zhejiang Xianju Pharmaceutical
11.8.1 Zhejiang Xianju Pharmaceutical Company Details
11.8.2 Zhejiang Xianju Pharmaceutical Business Overview
11.8.3 Zhejiang Xianju Pharmaceutical Testosterone Undecylate (TU) Introduction
11.8.4 Zhejiang Xianju Pharmaceutical Revenue in Testosterone Undecylate (TU) Business (2016-2021)
11.8.5 Zhejiang Xianju Pharmaceutical Recent Development
11.9 Zhejiang Medicine
11.9.1 Zhejiang Medicine Company Details
11.9.2 Zhejiang Medicine Business Overview
11.9.3 Zhejiang Medicine Testosterone Undecylate (TU) Introduction
11.9.4 Zhejiang Medicine Revenue in Testosterone Undecylate (TU) Business (2016-2021)
11.9.5 Zhejiang Medicine Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

ページTOPに戻る

Table of Contents

Summary

Testosterone undecanoate is the ester prodrug of testosterone and has a midchain fatty acid at the 17Beta position.It is available as an intramuscular injection and as an oral capsule, and is indicated for treatment of testosterone deficiency.

Market Analysis and Insights: Global Testosterone Undecylate (TU) Market
The global Testosterone Undecylate (TU) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Testosterone Undecylate (TU) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Testosterone Undecylate (TU) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Testosterone Undecylate (TU) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Testosterone Undecylate (TU) market.

Global Testosterone Undecylate (TU) Scope and Market Size
Testosterone Undecylate (TU) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Testosterone Undecylate (TU) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Injection
Oral

Segment by Application
Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Organon
Bayer AG
Endo Pharmaceuticals
Merck Sharp & Dohme
Taro Pharmaceutical
Cipla
Clarus Therapeutics
Zhejiang Xianju Pharmaceutical
Zhejiang Medicine

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

本レポートと同分野の最新刊レポートはありません。

QYResearch社の
Fatal error: Uncaught TypeError: Cannot access offset of type string on string in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php:630 Stack trace: #0 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68d51da90169e8_18903235() #1 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #2 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #3 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(385): Smarty_Internal_Template->render() #4 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/f20300271f4eb0fb4a2cf788aaabb06be5646d19_0.file.frame-FULL.tpl.php(278): Smarty_Internal_Template->_subTemplateRender() #5 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68b0f61a4d9868_07068969() #6 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #7 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #8 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(238): Smarty_Internal_Template->render() #9 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(134): Smarty_Internal_TemplateBase->_execute() #10 /var/www/vhosts/dri.co.jp/httpdocs/auto/show_report.php(776): Smarty_Internal_TemplateBase->display() #11 {main} thrown in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php on line 630

ウンデシル酸テストステロン（TU）の世界および日本の市場規模、現状、予測 2021-2027年

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野の最新刊レポート